首页> 外文期刊>Clinical and experimental obstetrics and gynecology >First trimester maternal serum PAPP-A levels and associated pregnancy complications in intrahepatic cholestasis of pregnancy
【24h】

First trimester maternal serum PAPP-A levels and associated pregnancy complications in intrahepatic cholestasis of pregnancy

机译:妊娠肝内胆汁淤积症孕早期孕妇血清PAPP-A水平及相关妊娠并发症

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To investigate first trimester maternal serum pregnancy associated plasma protein A (PAPP-A) multiple of the median (MoM) in cases with intrahepatic cholestasis of pregnancy (ICP). Obstetric complications and relation with PAPP-A MoM were also evaluated. Materials and Methods: This was a retrospective case-control study. After exclusions, for each ICP case, two controls with uncomplicated singleton pregnancies were randomly selected. PAPP-A MoM of ICP cases with and without obstetric complications, and the control group were compared with each other. Results: Total incidence of ICP was 0.99 % (138/13988). The study included 113 singleton pregnant women. Rates of gestational diabetes mellitus (GDM), preeclampsia (PE), fetal growth restriction (FGR), preterm labor (PTL), and hypothyroidism in cases with ICP were 21.2%, 7.9%, 10.6%, 18.6%, and 5.3%, respectively. Median PAPP-A MoM were 0.93 in ICP group and 1.10 in control group (p > 0.05). PAPP-A MoM levels were not significantly different either between the ICP group with complicated pregnancies and the control group or between the ICP group without complicated pregnancies and the control group (p>0.05). Conclusion: ICP incidence was similar to other European countries. Rates of obstetric complications expecially GDM were higher than expected in general pregnant population. ICP is not considered as pregnancy complications that have low PAPP-A MoM levels.
机译:目的:探讨妊娠肝内胆汁淤积(ICP)病例中孕早期孕妇血清妊娠相关血浆蛋白A(PAPP-A)中位数(MoM)的倍数。还评估了产科并发症及其与PAPP-A MoM的关系。材料和方法:这是一项回顾性病例对照研究。排除后,对于每例ICP病例,随机选择两个单纯妊娠的对照。将ICP患者有或没有产科并发症的PAPP-A MoM与对照组进行比较。结果:ICP的总发生率为0.99%(138/13988)。该研究包括113名单身孕妇。 ICP患者的妊娠糖尿病(GDM),先兆子痫(PE),胎儿生长受限(FGR),早产(PTL)和甲状腺功能减退的发生率分别为21.2%,7.9%,10.6%,18.6%和5.3%,分别。 ICP组中位数PAPP-A MoM为0.93,对照组中位数为1.10(p> 0.05)。妊娠合并ICP组与对照组之间,妊娠合并ICP与对照组之间,PAPP-A MoM水平均无显着性差异(p> 0.05)。结论:ICP发病率与其他欧洲国家相似。特别是GDM的产科并发症发生率高于一般孕妇。 ICP不被认为是低PAPP-A MoM水平的妊娠并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号